Kazia Therapeutics Ltd ADR (KZIA) Financials

KZIA Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 47.5 million 16.4 million
Sept. 30, 2025 4.0 million 9.5 million
June 30, 2025 4.0 million 9.4 million
Dec. 31, 2024 11.1 million 13.5 million

KZIA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -6.1 million ?
Sept. 30, 2025 ? ?
June 30, 2025 ? ?
Dec. 31, 2024 -2.6 million 144279

KZIA Net Income

No data available :(

KZIA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 46.3 million - -
Sept. 30, 2025 2.9 million - -
June 30, 2025 2.9 million - -
Dec. 31, 2024 1.9 million - -

KZIA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 2.1 million
Sept. 30, 2025 1.0 million
June 30, 2025 532.3 million
Dec. 31, 2024 528364

KZIA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 4 3.3 million 5.6 million -
Sept. 30, 2025 2.7 million 2.0 million - -
June 30, 2025 2.7 million 1.9 million 2.3 million -
Dec. 31, 2024 - 2.7 million 3.2 million -

KZIA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 - -
Sept. 30, 2025 13029 -
June 30, 2025 12961 -
Dec. 31, 2024 13850 -

KZIA

Price: $7.25

52 week price:
4.86
17.40

Earnings Per Share: -7.68 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 38900

Market Capitalization: 15.0 million

Links: